Quipt Home Medical Is Maintained at Buy by Benchmark
Quipt Home Medical Is Maintained at Buy by Benchmark
Benchmark Maintains Buy on Quipt Home Medical, Lowers Price Target to $9
Benchmark analyst Bill Sutherland maintains Quipt Home Medical (NASDAQ:QIPT) with a Buy and lowers the price target from $10 to $9.
Quipt Home Medical Corp. Price Target Cut to $2.50/Share From $10.00 by Raymond James
Quipt Home Medical Corp. Price Target Cut to $2.50/Share From $10.00 by Raymond James
Quipt Home Medical Is Maintained at Buy by Canaccord Genuity
Quipt Home Medical Is Maintained at Buy by Canaccord Genuity
Canadian Investment Banking Group: Maintaining the Quipt Home Medical (QIPT.US) rating, adjusted from buy to buy rating, and adjusted the target price from $9.00 to $8.00.
Canadian Investment Banking Group: Maintaining the Quipt Home Medical (QIPT.US) rating, adjusted from buy to buy rating, and adjusted the target price from $9.00 to $8.00.
Canaccord Genuity Maintains Buy on Quipt Home Medical, Lowers Price Target to $8
Canaccord Genuity analyst Richard Close maintains Quipt Home Medical (NASDAQ:QIPT) with a Buy and lowers the price target from $9 to $8.
Quipt Home Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/17/2024 150.78% Canaccord Genuity $9 → $8 Maintains Buy 02/16/2024 213.48% Raymond James $10 → $10 Down
Earnings Call Summary | Quipt Home Medical(QIPT.US) Q2 2024 Earnings Conference
The following is a summary of the Quipt Home Medical Corp. (QIPT) Q2 2024 Earnings Call Transcript:Financial Performance:Quipt Home Medical Corp reported Q2 revenues of $64 million, a 10% year-over-ye
Quipt Home Medical Corp. (QIPT) Q2 2024 Earnings Call Transcript
Quipt Home Medical Corp. (NASDAQ:QIPT) Q2 2024 Earnings Conference Call May 16, 2024 10:00 AM ET
Quipt Home Medical Shares Drop After Quarterly Loss Widens
By Robb M. Stewart Quipt Home Medical's shares fell sharply after the home medical equipment provider's loss unexpectedly widened in the latest quarter as the company was buffeted by a number of chal
Quipt Home Medical Reports Solid Growth in Q2
Quipt Home Medical Reports Positive Q2 Growth
Quipt Home Medical (QIPT.US): The 2024 Q2 financial report achieved revenue of US$64 million, with a previous value of US$58.12 million, with an expected value of US$65.59 million; earnings per share was -0.03 USD, previous value of -0.02 USD, and expecte
Quipt Home Medical (QIPT.US): The 2024 Q2 financial report achieved revenue of US$64 million, with a previous value of US$58.12 million, with an expected value of US$65.59 million; earnings per share was -0.03 USD, previous value of -0.02 USD, and expected value of $0.01.
Quipt Home Medical Q2 2024 GAAP EPS $(0.03) Misses $0.01 Estimate, Sales $64.000M Miss $65.590M Estimate
Quipt Home Medical (NASDAQ:QIPT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.01 by 400 percent. This is a 50 percent decrease over losses of $(0.02
Quipt Home Medical Corp. Brief: Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue
05:02 PM EDT, 05/15/2024 (MT Newswires) -- Quipt Home Medical Corp. Brief: Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue
Quipt Home Medical Corp. Brief: Revenue for Q2 2024 Was US$64.0 Million Compared to $58.1 Million for Q2 2023, Representing a 10% Increase
05:02 PM EDT, 05/15/2024 (MT Newswires) -- Quipt Home Medical Corp. Brief: Revenue for Q2 2024 was US$64.0 million compared to $58.1 million for Q2 2023, representing a 10% increase
Quipt Home Medical 2Q Loss/Shr 3c >QIPT.T
Quipt Home Medical 2Q Loss/Shr 3c >QIPT.T
Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10% and Adjusted EBITDA Growth of 14%
Quipt Home Medical Corp.(NASDAQ: QIPT; TSX: QIPT) today announced its second quarter fiscal 2024 financial results and operational highlights.
Quipt Home Medical Readies for Growth With New Shelf Prospectus
Quipt Home Medical Expands Financial Horizons
No Data